NCI Early-Stage Innovative Cancer Technology Development R61 Grant 2026

NCI Early-Stage Innovative Cancer Technology Development R61 Grant 2026

Due Date: 11/10/2026

The National Cancer Institute (NCI) Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research R61 Grant supports high-risk, high-impact projects developing novel technologies for the molecular or cellular characterization of cancer or for improved handling and quality control of cancer-relevant biospecimens.

The program focuses on early proof-of-concept and pilot development of new methods, tools, assays, platforms, devices, and instruments with potential to advance basic, clinical, or epidemiological cancer research. Awards provide up to $150,000 in direct costs per year for up to three years, with the next deadline on November 10, 2026.

Eligibility Criteria

  • Eligible applicants include public and private institutions of higher education.
  • Nonprofit organizations, with or without 501(c)(3) status, may apply.
  • Foreign/non-U.S. organizations are eligible to apply.
  • Non-U.S. components of U.S. organizations and eligible foreign components are permitted.
  • Applications involving foreign subawards or subcontracts are not permitted under the current NIH policy applicable to this NOFO.
  • Applicant organizations may submit multiple applications if each proposal is scientifically distinct.

Funding Details

  • Maximum funding: $150,000 in direct costs per year.
  • Maximum project duration: 3 years.
  • Maximum potential direct costs: $450,000 over three years.
  • NCI FY2027 program funding: Approximately $5.1 million.

Deadline

  • Applications opened: June 10, 2026.
  • Application deadline: November 10, 2026.
  • Earliest project start: July 2027.
  • NOFO expiration: November 11, 2026.

Further Information

  • Projects simply applying an existing technology to a new biological or clinical question are not eligible.
  • Biomarker discovery or validation, drug or therapy development, whole-body/in vivo imaging instrumentation, and software/informatics-only projects are outside the scope of this call.
  • Awardees must participate in the annual NCI IMAT investigator meeting, and relevant travel costs may be included in the project budget.
  • Official program page: View the official opportunity
  • Full announcement: View RFA-CA-27-001
  • Grants.gov listing: View on Grants.gov